Researchers from Harvard Medical School have developed an AI model, Clinical Histopathology Imaging Evaluation Foundation (CHIEF), which can analyse multiple forms of cancer with great versatility and accuracy. CHIEF can predict patient outcomes and validate its results across different international groups. Unlike similar models based on pathology images, the system can predict patient outcomes and validate results across various patient groups. The model works by reading digital slides of tumour tissues, identifying genes and DNA patterns related to treatment responses.
Linux Kernel KSMBD Flaw Lets Remote Attackers Drain Server Resources
A critical vulnerability in the Linux kernel’s KSMBD implementation has been discovered that allows remote attackers to completely exhaust server connection resources through a simple
